Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation: consultative hemostasis.

Julie Hambleton1, Lawrence L Leung, Marcel Levi

  • 1Hemostasis and Thrombosis, Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, 94143, USA.

Hematology. American Society of Hematology. Education Program
|November 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the comment by Gando on the updated definition and scoring of disseminated intravascular coagulation.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Laboratory and Medicine 2.1: Care for What You Wish for.

International journal of laboratory hematology·2026
Same author

Deficiencies of carboxypeptidase N and carboxypeptidase B2 have opposite effects in a virulent mouse E. coli sepsis model.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Organ Dysfunction in Sepsis-associated Intravascular Coagulation.

Juntendo Iji zasshi = Juntendo medical journal·2024
Same author

Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?

Journal of thrombosis and haemostasis : JTH·2024
Same journal

Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program. 2023;2023(1):382-385.

Hematology. American Society of Hematology. Education Program·2025
Same journal

CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Anticoagulants in hematologic malignancies: what is the data?

Hematology. American Society of Hematology. Education Program·2025
Same journal

Diagnosis and management of cold agglutinin disease.

Hematology. American Society of Hematology. Education Program·2025
Same journal

What to know about rare B-cell malignancies in 2025.

Hematology. American Society of Hematology. Education Program·2025
See all related articles

This review updates clinical hematologists on advances in disseminated intravascular coagulation (DIC) and thrombosis management in hospitalized patients. It covers pathogenic mechanisms, novel therapies for DIC, refractory thrombosis, and hemostatic complications in solid organ transplantation.

Area of Science:

  • Hematology
  • Thrombosis
  • Coagulopathy

Background:

  • Clinical hematologists manage complex coagulopathies in hospitalized patients.
  • Disseminated intravascular coagulation (DIC) and thrombosis present significant inpatient challenges.
  • Hemostasis management in solid organ transplantation requires specialized knowledge.

Purpose of the Study:

  • To provide an update on scientific and clinical advances in DIC.
  • To discuss challenges in inpatient thrombosis management.
  • To review hemostatic complications in solid organ transplantation.

Main Methods:

  • Review of pathogenic mechanisms and novel therapeutic strategies for DIC.
  • Overview of challenging inpatient thrombosis cases, including refractory DVT and mesenteric thrombosis.

Related Experiment Videos

  • Examination of hemostatic complications in solid organ transplantation, focusing on liver transplantation.

    • Main Results:

    • Advances in understanding DIC pathogenesis and novel treatment evaluations, particularly in sepsis.
    • Discussion of refractory thrombosis, PF4/heparin ELISA interpretation, and novel treatments for dialysis catheter thrombosis.
    • Emphasis on coagulopathy in liver transplantation, thrombophilia, drug-induced microangiopathy, and postoperative prophylaxis.

    Conclusions:

    • Current understanding and therapeutic strategies for DIC have advanced.
    • Inpatient thrombosis presents complex scenarios requiring tailored management.
    • Effective management of hemostatic complications is crucial for solid organ transplant outcomes.